VERACYTE, INC.·4

Nov 8, 5:44 PM ET

Kennedy Giulia C 4

4 · VERACYTE, INC. · Filed Nov 8, 2022

Insider Transaction Report

Form 4
Period: 2022-11-04
Kennedy Giulia C
Chief Scientific & Med Officer
Transactions
  • Sale

    Common Stock

    2022-11-04$25.00/sh1,023$25,57568,001 total
Footnotes (1)
  • [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 14, 2022.

Documents

1 file
  • 4
    wf-form4_166794747255272.xmlPrimary

    FORM 4